Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Transcriptome-wide association analysis identifies DACH1 as a kidney disease risk gene that contributes to fibrosis
Tomohito Doke, … , Richard Pestell, Katalin Susztak
Tomohito Doke, … , Richard Pestell, Katalin Susztak
Published May 17, 2021
Citation Information: J Clin Invest. 2021;131(10):e141801. https://doi.org/10.1172/JCI141801.
View: Text | PDF
Research Article Genetics Nephrology

Transcriptome-wide association analysis identifies DACH1 as a kidney disease risk gene that contributes to fibrosis

  • Text
  • PDF
Abstract

Genome-wide association studies (GWAS) for kidney function identified hundreds of risk regions; however, the causal variants, target genes, cell types, and disease mechanisms remain poorly understood. Here, we performed transcriptome-wide association studies (TWAS), summary Mendelian randomization, and MetaXcan to identify genes whose expression mediates the genotype effect on the phenotype. Our analyses identified Dachshund homolog 1 (DACH1), a cell-fate determination factor. GWAS risk variant was associated with lower DACH1 expression in human kidney tubules. Human and mouse kidney single-cell open chromatin data (snATAC-Seq) prioritized estimated glomerular filtration rate (eGFR) GWAS variants located on an intronic regulatory region in distal convoluted tubule cells. CRISPR-Cas9–mediated gene editing confirmed the role of risk variants in regulating DACH1 expression. Mice with tubule-specific Dach1 deletion developed more severe renal fibrosis both in folic acid and diabetic kidney injury models. Mice with tubule-specific Dach1 overexpression were protected from folic acid nephropathy. Single-cell RNA sequencing, chromatin immunoprecipitation, and functional analysis indicated that DACH1 controls the expression of cell cycle and myeloid chemotactic factors, contributing to macrophage infiltration and fibrosis development. In summary, integration of GWAS, TWAS, single-cell epigenome, expression analyses, gene editing, and functional validation in different mouse kidney disease models identified DACH1 as a kidney disease risk gene.

Authors

Tomohito Doke, Shizheng Huang, Chengxiang Qiu, Hongbo Liu, Yuting Guan, Hailong Hu, Ziyuan Ma, Junnan Wu, Zhen Miao, Xin Sheng, Jianfu Zhou, Aili Cao, Jianhua Li, Lewis Kaufman, Adriana Hung, Christopher D. Brown, Richard Pestell, Katalin Susztak

×

Figure 5

Mice with tubule-specific Dach1 loss are more susceptible to diabetic injury.

Options: View larger image (or click on image) Download as PowerPoint
Mice with tubule-specific Dach1 loss are more susceptible to diabetic in...
(A) Experimental design: WT, KspCre/Dach1fl/WT (Dach1 HZ), and KspCre/Dach1fl/fl (Dach1 KO) mice underwent nephrectomy and STZ injection. (B) Urine albumin-to-creatinine ratio at 6, 14, 18, and 22 weeks of age. The x axis indicates age (weeks). Black line, WT; red line, KspCre/Dach1fl/WT (Dach1 HZ); green line, KspCre/Dach1fl/fl (Dach1 KO). aP < 0.05, Dach1 KO vs. WT; bP < 0.01, Dach1 KO vs. WT; P < 0.05, Dach1 KO vs. Dach1 HZ; P < 0.05, Dach1 HZ vs. WT. (C) Blood glucose levels of sham-treated and Unx-STZ–treated groups. (D–F) Relative transcript levels of Col1a1 (D), Col3a1 (E), and Fn1 (F) in whole kidney samples of WT, KspCre/Dach1fl/WT (Dach1 HZ), and KspCre/Dach1fl/fl (Dach1 KO) mice. Gene expression levels were normalized to Gapdh. (B–F) Sham-treated group: WT (n = 3), Dach1 HZ (n = 3), Dach1 KO (n = 3); Unx-STZ treatment group: WT (n = 7), Dach1 HZ (n = 8), Dach1 KO (n = 6). *P < 0.05, **P < 0.01, ***P < 0.001, 1-way ANOVA and Tukey’s post hoc test.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts